Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Rocket Lab USA, Inc.
RKLB
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By geography
See full
Rest of world
7%
-12.5%
Other financials
Income statement
See full
Revenue
$200.3M
+63.5%
Gross profit
$76.5M
+117%
Operating income
-$56.0M
+5.4%
Net income
-$45.0M
+25.7%
EPS (diluted)
-$0.07
+41.7%
Balance sheet
See full
Cash & equivalents
$1.2B
+293%
Total debt
$101.8M
-29.2%
Total equity
$2.3B
+425%
Total assets
$2.8B
+125%
Cash flow
See full
Operating cash flow
-$50.3M
+7.2%
CapEx
$27.1M
-5.6%
Free cash flow
-$77.4M
+6.6%
Valuation
See full
Market cap
$50.42B
+264%
Enterprise value
$49.31B
+260%
P/S
74.2×
+44.4×
Profitability
See full
Gross margin
36.6%
+9.3pp
Operating margin
-33.2%
-6.6pp
Net margin
-26.9%
-7.6pp
FCF margin
-46.5%
+13.5pp
Returns & leverage
See full
Return on equity
-13.5%
-5.6pp
Debt / equity
0×
-0.3×
Current ratio
4.5×
+2.4×